Vascular Pathways (Los Altos, CA) a clinical-stage medical device company focused on rapid peripheral intravenous access, closed a $14M Series B financing. Participants include CHL Medical Partners, Ascension Health Ventures, MVM Life Science Partners and Arcus Ventures.

Cara Therapeutics (Shelton, CT) a clinical-stage small molecule company focused on pain and inflammation, closed a $15M Series D financing. Participants include Rho Ventures, Alta Partners, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Mitsubishi International and MVM Life Science Partners.

Cheetah Medical (Israel) a commercial-stage device company focused on non-invasive cardiac output and hemodynamic monitoring, closed a $20M Series B financing. Participants include Ascension Health Ventures, Robert Bosch Venture Capital and MVM Life Science Partners.

BioVex (Woburn, MA) a clinical-stage biologics company focused on metastatic melanoma, head and neck, pancreatic and colo-rectal cancer, closed a $30M Series F bringing the entire round to $70M. Participants have included Morningside Venture, Ventech, MVM Life Science Partners, Sectoral Asset Management, Ysios Capital Partners, Forbion Capital Partners, Credit Agricole Private Equity, Harris & Harris [...]

Tarsa Therapeutics (Boonton, NJ) a clinical stage small molecule company focused on osteoporosis closed a $24M Series A financing. Participants include MVM Life Science Partners, Quaker BioVentures and Novo Ventures.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.